Involvement of mast cells in the regulation of matrix metalloproteinase-9 and tissue inhibitor of metalloproteases-1 in 12-O-tetradecanoylphorbolacetate-induced inflammation in mice

International Immunopharmacology

Volumn 7, Issue 5, 2007, Pages 597-603

  Iba, Yoshinori ^a   Shirai, Maiko ^a   Dei, Chiaki ^a   Hirata, Takahiro ^a   Harada, Chika ^a   Masukawa, Tohru ^a  

^a SETSUNAN UNIVERSITY   (Japan)

Author keywords

Inflammation; Mast cells; MMP 9; TIMP 1

Indexed keywords

ENZYME PRECURSOR; GELATINASE B; PHORBOL 13 ACETATE 12 MYRISTATE; TISSUE INHIBITOR OF METALLOPROTEINASE 1;

ADOLESCENT; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CELL FUNCTION; CONTROLLED STUDY; ENZYME ACTIVATION; ENZYME REGULATION; INFLAMMATION; MALE; MAST CELL; MAST CELL DEGRANULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL; REGULATORY MECHANISM; SWELLING; WESTERN BLOTTING; ZYMOGRAPHY;

ANIMALS; BLOTTING, WESTERN; CELL DEGRANULATION; EAR, EXTERNAL; INFLAMMATION; MAST CELLS; MATRIX METALLOPROTEINASE 9; MICE; TETRADECANOYLPHORBOL ACETATE; TISSUE INHIBITOR OF METALLOPROTEINASE-1;

EID: 33947385742     PISSN: 15675769     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.intimp.2006.12.012     Document Type: Article

References (26)

1. Stamenkovic I. Extracellular matrix remodelling: the role of matrix metalloproteinases. J Pathol 200 (2003) 448-464
2. Kahari V.M., and Saarialho-Kere U. Matrix metalloproteinases in skin. Exp Dermatol 6 (1997) 199-213
3. Opdenakker G., Van den Steen P.E., Dubois B., Nelissen I., Van Coillie E., Masure S., et al. Gelatinase B functions as regulator and effector in leukocyte biology. J Leukoc Biol 69 (2001) 851-859
4. Benbow U., and Brinckerhoff C.E. The AP-1 site and MMP gene regulation: what is all the fuss about?. Matrix Biol 15 (1997) 519-526
5. Ogata Y., Itoh Y., and Nagase H. Steps involved in activation of the pro-matrix metalloproteinase 9 (progelatinase B)-tissue inhibitor of metalloproteinases-1 complex by 4-aminophenylmercuric acetate and proteinases. J Biol Chem 270 (1995) 18506-18511
6. Brew K., Dinakarpandian D., and Nagase H. Tissue inhibitors of metalloproteinases: evolution, structure and function. Biochim Biophys Acta 1477 (2000) 267-283
7. Hiromatsu Y., and Toda S. Mast cells and angiogenesis. Microsc Res Tech 60 (2003) 64-69
8. Iba Y., Shibata A., Kato M., and Masukawa T. Possible involvement of mast cells in collagen remodeling in the late phase of cutaneous wound healing in mice. Int Immunopharmacol 4 (2004) 1873-1880
9. Tchougounova E., Lundequist A., Fajardo I., Winberg J.O., Abrink M., and Pejler G. A key role for mast cell chymase in the activation of pro-matrix metalloprotease-9 and pro-matrix metalloprotease-2. J Biol Chem 280 (2005) 9291-9296
10. Fang K.C., Raymond W.W., Blount J.L., and Caughey G.H. Dog mast cell alpha-chymase activates progelatinase B by cleaving the Phe88-Gln89 and Phe91-Glu92 bonds of the catalytic domain. J Biol Chem 272 (1997) 25628-25635
11. Fang K.C., Raymond W.W., Lazarus S.C., and Caughey G.H. Dog mastocytoma cells secrete a 92-kD gelatinase activated extracellularly by mast cell chymase. J Clin Invest 97 (1996) 1589-1596
12. Coussens L.M., Raymond W.W., Bergers G., Laig-Webster M., Behrendtsen O., Werb Z., et al. Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13 (1999) 1382-1397
13. Wershil B.K., Murakami T., and Galli S.J. Mast cell-dependent amplification of an immunologically nonspecific inflammatory response. Mast cells are required for the full expression of cutaneous acute inflammation induced by phorbol 12-myristate 13-acetate. J Immunol 140 (1988) 2356-2360
14. Janoff A., Klassen A., and Troll W. Local vascular changes induced by the cocarcinogen, phorbol myristate acetate. Cancer Res 30 (1970) 2568-2571
15. Liu J.F., Crepin M., Liu J.M., Barritault D., and Ledoux D. FGF-2 and TPA induce matrix metalloproteinase-9 secretion in MCF-7 cells through PKC activation of the Ras/ERK pathway. Biochem Biophys Res Commun 293 (2002) 1174-1182
16. Hanemaaijer R., Koolwijk P., le Clercq L., de Vree W.J., and van Hinsbergh V.W. Regulation of matrix metalloproteinase expression in human vein and microvascular endothelial cells. Effects of tumour necrosis factor alpha, interleukin 1 and phorbol ester. Biochem J 296 Pt 3 (1993) 803-809
17. Mackay A.R., Ballin M., Pelina M.D., Farina A.R., Nason A.M., Hartzler J.L., et al. Effect of phorbol ester and cytokines on matrix metalloproteinase and tissue inhibitor of metalloproteinase expression in tumor and normal cell lines. Invasion Metastasis 12 (1992) 168-184
18. Olson M.W., Bernardo M.M., Pietila M., Gervasi D.C., Toth M., Kotra L.P., et al. Characterization of the monomeric and dimeric forms of latent and active matrix metalloproteinase-9. Differential rates for activation by stromelysin 1. J Biol Chem 275 (2000) 2661-2668
19. Okada Y., Gonoji Y., Naka K., Tomita K., Nakanishi I., Iwata K., et al. Matrix metalloproteinase 9 (92-kDa gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. Purification and activation of the precursor and enzymic properties. J Biol Chem 267 (1992) 21712-21719
20. Frank B.T., Rossall J.C., Caughey G.H., and Fang K.C. Mast cell tissue inhibitor of metalloproteinase-1 is cleaved and inactivated extracellularly by alpha-chymase. J Immunol 166 (2001) 2783-2792
21. Han R., and Smith T.J. Induction by IL-1 beta of tissue inhibitor of metalloproteinase-1 in human orbital fibroblasts: modulation of gene promoter activity by IL-4 and IFN-gamma. J Immunol 174 (2005) 3072-3079
22. Itoh Y., and Nagase H. Preferential inactivation of tissue inhibitor of metalloproteinases-1 that is bound to the precursor of matrix metalloproteinase 9 (progelatinase B) by human neutrophil elastase. J Biol Chem 270 (1995) 16518-16521
23. McMillan S.J., Kearley J., Campbell J.D., Zhu X.W., Larbi K.Y., Shipley J.M., et al. Matrix metalloproteinase-9 deficiency results in enhanced allergen-induced airway inflammation. J Immunol 172 (2004) 2586-2594
24. Corry D.B., Kiss A., Song L.Z., Song L., Xu J., Lee S.H., et al. Overlapping and independent contributions of MMP2 and MMP9 to lung allergic inflammatory cell egression through decreased CC chemokines. Faseb J 18 (2004) 995-997
25. Wang M., Qin X., Mudgett J.S., Ferguson T.A., Senior R.M., and Welgus H.G. Matrix metalloproteinase deficiencies affect contact hypersensitivity: stromelysin-1 deficiency prevents the response and gelatinase B deficiency prolongs the response. Proc Natl Acad Sci U S A 96 (1999) 6885-6889
26. Fassina G., Ferrari N., Brigati C., Benelli R., Santi L., Noonan D.M., et al. Tissue inhibitors of metalloproteases: regulation and biological activities. Clin Exp Metastasis 18 (2000) 111-120